(NASDAQ: BDSX) Biodesix's forecast annual revenue growth rate of 32.42% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 3.74%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.23%.
Biodesix's revenue in 2024 is $49,087,000.On average, 1 Wall Street analysts forecast BDSX's revenue for 2024 to be $6,301,233,965, with the lowest BDSX revenue forecast at $6,301,233,965, and the highest BDSX revenue forecast at $6,301,233,965.
In 2025, BDSX is forecast to generate $7,328,819,812 in revenue, with the lowest revenue forecast at $7,328,819,812 and the highest revenue forecast at $7,328,819,812.